NATIONAL ASTHMA EDUCATION PREVENTION PROGRAM COORDINATING COMMITTEE
Authorized by 424B of the Public Health Service Act, 42 U.S.C. 285b-7b, as amended. The National Asthma Education Prevention Program (NAEPP) Coordinating Committee (Committee) is governed by the provisions of the Federal Advisory Committee Act, as amended (5 U.S.C App.), which sets forth standards for the formation and use of advisory committees.
OBJECTIVES AND SCOPE OF ACTIVITIES
The NAEPP was created to address asthma issues in the United States. The objectives of the Committee are to: (1) raise awareness of patients, health professionals, and the public that asthma is a serious chronic disease and to ensure the recognition of the symptoms of asthma by patients, families, and the public and the appropriate diagnosis by health professionals, (2) continually identify Federal programs that carry out asthma-related activities; and 3) develop or update, in consultation with appropriate Federal agencies and professional voluntary health organizations, the Federal plan for responding to asthma to aid in effective control of asthma by encouraging a partnership among federal agencies, patients, physicians, and other health professionals through modern treatment and education programs.
To accomplish these broad program goals, the Committee is made up of members from the National Heart, Lung, and Blood Institute (NHLBI), as well as other federal agencies, intermediaries including major medical associations, voluntary health organizations, and community programs and strives to educate patients, health professionals, and the public. The ultimate goal of the NAEPP is to enhance the quality of life for patients with asthma and decrease asthma-related morbidity and mortality.
DESCRIPTION OF DUTIES
The Committee’s primary mission is to provide advice to the NHLBI on matters concerning asthma and to facilitate the efficient and effective exchange of information on asthma activities among the member agencies and voluntary health organizations in order to enhance coordination of asthma-related programs and activities. The Committee will assist in increasing public understanding of the member agencies’ activities, programs, policies, and research and will serve as a public forum for discussion of issues related to asthma.
AGENCY OR OFFICIAL TO WHOM THE COMMITTEE REPORTS
The Committee will advise, assist, consult with, and make recommendations to the Director, National Institutes of Health (NIH), and the Director, National Heart, Lung, and Blood Institute (NHLBI).
Management and support services will be provided by the Center for Translation Research and Implementation Science (CTRIS) and Division of Lung Diseases (DLD), NHLBI.
ESTIMATED ANNUAL OPERATING COST AND STAFF YEARS
The estimated annual cost for operating the Committee, excluding staff support, is $68,585. The estimated annual person-years of staff support required are 0.3, at an estimated annual cost of $34,146.
DESIGNATED FEDERAL OFFICER
The Director, NHLBI, will assign a full-time or permanent part-time NHLBI employee as the Designated Federal Officer (DFO) of the Committee. In the event that the DFO cannot fulfill the assigned duties of the Committee, one or more full-time or permanent part-time NHLBI or NIH employees will be assigned these duties on a temporary basis.
The DFO will approve or call all of the Committee’s and subcommittees’ meetings, prepare and approve all meeting agendas, attend all Committee and subcommittee meetings, adjourn any meeting when it is determined to be in the public interest, and chair meetings when directed to do so by the Director, NHLBI.
ESTIMATED NUMBER AND FREQUENCY OF MEETINGS
The Committee will meet approximately two times per year. Meetings will be open to the public except as determined otherwise by the Secretary of DHHS in accordance with subsection (c) of section 552b of Title 5 U.S.C. Notice of all meetings will be given to the public. In the event a portion of a meeting is closed to the public, as determined by the Secretary in accordance with the Government in the Sunshine Act (5 U.S.C. 552b(c)) and the Federal Advisory Committee Act, a report will be prepared which will contain, as a minimum, a list of members and their business addresses, the Committee’s functions, dates and places of meetings, and a summary of the Committee’s activities and recommendations made during the fiscal year. A copy of the report shall be provided to the Department Committee Management Officer.
Unless renewed by appropriate action, the charter of the National Asthma Education Prevention Program Coordinating Committee will terminate two years from the date the charter is filed.
MEMBERSHIP AND DESIGNATION
The Committee will consist of up to 15 voting members. Members will consist of Federal employees, Special Government Employees (SGEs), and Representatives. In addition, one official from the Division of Lung Diseases, and one official from the Center for Translation Research and Implementation Science will serve as co-Chairs of the Committee.
At least three members will represent government agencies, from among the NIH national research institutes and centers involved in research with respect to asthma, the Department of Housing and Urban Development, the Centers for Disease Control and Prevention, or any other Federal departments and agencies whose programs involve health functions or responsibilities relevant to this disease.
At least three non-Federal members will serve as Special Government Employees selected from the health and scientific disciplines with respect to asthma. These members will be invited to serve up to four-year terms.
At least three non-Federal members will serve as Representatives from professional societies, voluntary health organizations, and community programs whose purpose is to enhance the quality of life for patients with asthma and decrease asthma-related morbidity and mortality. These members will be invited to serve up to four-year terms. There may be only one Representative per organization.
Terms of more than two years are contingent upon the renewal of the Committee charter by appropriate action prior to its termination. Members may serve after the expiration of their terms until their successors have taken office. A quorum for the conduct of business by the full Committee will consist of a majority of currently appointed members.
As necessary, subcommittees and ad hoc working groups may be established by the DFO within the Committee’s jurisdiction. The advice/recommendations of a subcommittee/working group must be deliberated by the parent advisory committee. A subcommittee may not report directly to a Federal official unless there is statutory authority to do so.
Subcommittee membership may be drawn in whole or in part from the parent advisory committee. Subcommittee members may serve as Representatives. All subcommittee members may vote on subcommittee actions and all subcommittee members count towards the quorum for a subcommittee meeting. Ad hoc consultants do not count towards the quorum and may not vote. A quorum for a subcommittee will be three members. The Department Committee Management Officer will be notified upon establishment of each standing subcommittee and will be provided information on its name, membership, function, and estimated frequency of meetings.
Meetings of the Committee and its subcommittees will be conducted according to the Federal Advisory Committee Act, other applicable laws and Departmental policies. Committee and subcommittee records
will be handled in accordance with General Records Schedule 26, Item 2 or other approved agency records disposition schedule. These records will be available for public inspection and copying, subject to the Freedom of Information Act, 5 U.S.C. 552.
August 08, 2015
July 08, 2015 /Francis V. Collins/
Date Dr. Francis V. Collins, Director, NIH